A recent study has shown that SDMA is involved in the inflammatory process of CKD, by activating intracellular monocytic expression of interleukin 6 and tumor necrosis factor-alpha in vitro, whereas ADMA does not. This evidence concerns the gene IL6 and chronic kidney disease.